Further, previous studies showed that RTX-mediated ablation of the TRPV1-positive sensory fibers reduces imiquimod (IMQ)-induced psoriasis-like ear skin inflammation resulting from activation of the IL-23/IL-17 pathway in the dermal dendritic cells/γδ T cells28. This evidence concerns the gene IL17A and psoriasis.